Alicia Ault

Two new analyses of the SELECT trial show that the GLP-1 receptor agonist improves cardiovascular health and reduces or normalizes glycemic levels irrespective of baseline A1c.

Two new analyses of the STEP-HFpEF trials show that semaglutide led to more weight loss in women than in men and that the GLP-1 therapy also improves NYHA class.

State surveyors found that CRNAs were practicing beyond their scope at two hospitals in California.

A whistleblower alleged that three cardiothoracic surgeons delegated key aspects of surgery to “unqualified medical residents.”

Investigators also noted continuing disparities in prescribing, with women and Black and Hispanic individuals less likely to get an OUD medication.

Illicit use of the veterinary tranquilizer xylazine continues to spread in the United States. It often fails to respond to the overdose reversal agent naloxone and can cause severe necrotic lesions.

Are CGMs Banned in Olympics for Athletes Without Diabetes?

Pharmaceutical and medical device manufacturers paid cardiology fellows $13.3 million with the majority of the money going to those in procedural intensive subspecialties.

The US Food and Drug Administration has declined to approve MDMA-assisted therapy for the treatment of PTSD.

Two leaders of the controversial Front Line COVID-19 Critical Care Alliance are no longer certified by the American Board of Internal Medicine, ending a 2-year disciplinary process.